These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei. Van de Verg L, Herrington DA, Murphy JR, Wasserman SS, Formal SB, Levine MM. Infect Immun; 1990 Jun; 58(6):2002-4. PubMed ID: 1692813 [Abstract] [Full Text] [Related]
4. Stable expression of Shigella sonnei form I O-polysaccharide genes recombineered into the chromosome of live Salmonella oral vaccine vector Ty21a. Dharmasena MN, Hanisch BW, Wai TT, Kopecko DJ. Int J Med Microbiol; 2013 Apr; 303(3):105-13. PubMed ID: 23474241 [Abstract] [Full Text] [Related]
5. Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine. Black RE, Levine MM, Clements ML, Losonsky G, Herrington D, Berman S, Formal SB. J Infect Dis; 1987 Jun; 155(6):1260-5. PubMed ID: 2437220 [Abstract] [Full Text] [Related]
6. [Construction of a typhoid-dysentery bivalent strain with typhoid ty21a and dysentery T32-Istrati strains]. Chen QY, Jiang LJ, Kong DC, Wang BR. Wei Sheng Wu Xue Bao; 1987 Dec; 27(4):362-8. PubMed ID: 3329424 [No Abstract] [Full Text] [Related]
7. Unusual lipopolysaccharide antigens of a Salmonella typhi oral vaccine strain expressing the Shigella sonnei form I antigen. Seid RC, Kopecko DJ, Sadoff JC, Schneider H, Baron LS, Formal SB. J Biol Chem; 1984 Jul 25; 259(14):9028-34. PubMed ID: 6378905 [Abstract] [Full Text] [Related]
10. Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. Herrington DA, Van de Verg L, Formal SB, Hale TL, Tall BD, Cryz SJ, Tramont EC, Levine MM. Vaccine; 1990 Aug 25; 8(4):353-7. PubMed ID: 2204243 [Abstract] [Full Text] [Related]
13. Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial. McKenzie R, Walker RI, Nabors GS, Van De Verg LL, Carpenter C, Gomes G, Forbes E, Tian JH, Yang HH, Pace JL, Jackson WJ, Bourgeois AL. Vaccine; 2006 May 01; 24(18):3735-45. PubMed ID: 16095766 [Abstract] [Full Text] [Related]
15. Cell wall structures which may be important for successful immunization with Salmonella-Shigella hybrid vaccines. Schultz CL, Kaufman B, Hamilton D, Hartman A, Ruiz M, Powell C, Berman S. Vaccine; 1990 Apr 01; 8(2):115-20. PubMed ID: 2159678 [Abstract] [Full Text] [Related]
16. Antigenicity testing of inactivated oral enteric bacterial vaccines for human use. Joó I. Dev Biol Stand; 1976 Apr 01; 33():75-9. PubMed ID: 782974 [Abstract] [Full Text] [Related]
17. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a. Dharmasena MN, Osorio M, Takeda K, Stibitz S, Kopecko DJ. Clin Vaccine Immunol; 2017 Dec 01; 24(12):. PubMed ID: 29046309 [Abstract] [Full Text] [Related]
18. Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children. Cryz SJ, Vanprapar N, Thisyakorn U, Olanratmanee T, Losonsky G, Levine MM, Chearskul S. Infect Immun; 1993 Mar 01; 61(3):1149-51. PubMed ID: 8432597 [Abstract] [Full Text] [Related]
19. Intestinal immunoglobulin A responses in rabbits to a Salmonella typhi strain harboring a Shigella sonnei plasmid. Keren DF, Collins HH, Baron LS, Kopecko DJ, Formal SB. Infect Immun; 1982 Jul 01; 37(1):387-9. PubMed ID: 7049953 [Abstract] [Full Text] [Related]